Level Bio AB (publ) (NGM:LEVBIO)
0.2540
-0.0360 (-12.41%)
At close: Jun 12, 2026
Level Bio AB Market Cap
Level Bio AB has a market cap or net worth of 19.7 million as of June 15, 2026. Its market cap has decreased by -0.69% in one year.
Market Cap
19.70M
Enterprise Value
18.24M
Revenue
33.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since September 18, 2006, Level Bio AB's market cap has decreased from 35.14M to 19.70M, a decrease of -43.95%. That is a compound annual growth rate of -2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 19.70M | -4.00% |
| Dec 30, 2025 | 20.52M | 8.70% |
| Dec 30, 2024 | 18.88M | -27.02% |
| Dec 29, 2023 | 25.87M | -45.31% |
| Dec 30, 2022 | 47.30M | -70.97% |
| Dec 30, 2021 | 162.94M | 142.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nattaro Labs AB | 24.49M |
| Nexar Group AB | 23.58M |
| Hybricon AB | 21.96M |
| Vaxxa AB | 21.94M |
| edyoutec AB | 21.74M |
| Transiro Holding AB | 21.32M |
| Trainimal AB | 18.74M |
| Diadrom Holding AB | 17.62M |